{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:58:51Z","timestamp":1774969131485,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R01 AI137332"],"award-info":[{"award-number":["R01 AI137332"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R24 AI120942"],"award-info":[{"award-number":["R24 AI120942"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007000","name":"Laboratory Directed Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.peptides.2022.170844","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T02:05:08Z","timestamp":1658455508000},"page":"170844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["PCP consensus protein\/peptide alphavirus antigens stimulate broad spectrum neutralizing antibodies"],"prefix":"10.1016","volume":"157","author":[{"given":"Catherine H.","family":"Schein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Rafael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy S.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth S.","family":"Anaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurgen G.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott C.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra","family":"Negi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.peptides.2022.170844_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.1999.61.579","article-title":"Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America","volume":"61","author":"Brault","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"8","key":"10.1016\/j.peptides.2022.170844_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005693","article-title":"Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas","volume":"11","author":"Forrester","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.peptides.2022.170844_bib3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4269\/ajtmh.1999.60.630","article-title":"Geographic distribution of Venezuelan equine encephalitis virus subtype IE genotypes in Central America and Mexico","volume":"60","author":"Oberste","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.peptides.2022.170844_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4269\/ajtmh.1999.60.441","article-title":"Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks","volume":"60","author":"Weaver","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.peptides.2022.170844_bib5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2460\/javma.1994.205.07.1014","article-title":"Eastern equine encephalomyelitis virus infection in swine","volume":"205","author":"Elvinger","year":"1994","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.peptides.2022.170844_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2019.01.015","article-title":"New World alphavirus protein interactomes from a therapeutic perspective","volume":"163","author":"Carey","year":"2019","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.peptides.2022.170844_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3201\/eid2602.171636","article-title":"Emergence of Chikungunya Virus, Pakistan, 2016-2017","volume":"26","author":"Badar","year":"2020","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chom.2015.06.009","article-title":"Isolation and characterization of broad and ultrapotent human monoclonal antibodies with therapeutic activity against chikungunya virus","volume":"18","author":"Smith","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.peptides.2022.170844_bib9","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/v13112231","article-title":"Cross-strain neutralizing and protective monoclonal antibodies against EEEV or WEEV","volume":"13","author":"Phelps","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib10","doi-asserted-by":"crossref","first-page":"21076","DOI":"10.1038\/s41598-020-78009-7","article-title":"Infectious RNA vaccine protects mice against chikungunya virus infection","volume":"10","author":"Szurgot","year":"2020","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.peptides.2022.170844_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00775-19","article-title":"Chikungunya virus vaccine candidates with decreased mutational robustness are attenuated in vivo and have compromised transmissibility","volume":"93","author":"Carrau","year":"2019","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.peptides.2022.170844_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.4253","article-title":"A chikungunya fever vaccine utilizing an insect-specific virus platform","volume":"23","author":"Erasmus","year":"2017","journal-title":"Nat. Med."},{"issue":"50","key":"10.1016\/j.peptides.2022.170844_bib13","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1016\/j.vaccine.2018.10.033","article-title":"Defining a correlate of protection for chikungunya virus vaccines","volume":"37","author":"Milligan","year":"2019","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.peptides.2022.170844_bib14","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.peptides.2022.170844_bib15","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2013.05.059","article-title":"Deciphering the protective role of adaptive immunity to CHIKV\/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model","volume":"31","author":"Chu","year":"2013","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.peptides.2022.170844_bib16","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1016\/j.vaccine.2012.04.099","article-title":"Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine","volume":"30","author":"Partidos","year":"2012","journal-title":"Vaccine"},{"issue":"9959","key":"10.1016\/j.peptides.2022.170844_bib17","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.peptides.2022.170844_bib18","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1016\/j.vaccine.2018.05.095","article-title":"A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections","volume":"36","author":"Chattopadhyay","year":"2018","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.peptides.2022.170844_bib19","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","article-title":"Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus","volume":"30","author":"Kumar","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.peptides.2022.170844_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007316","article-title":"Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice","volume":"13","author":"Arevalo","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.peptides.2022.170844_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virusres.2012.05.004","article-title":"Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1\/Th2 response and virus-neutralizing antibodies in mice","volume":"167","author":"Khan","year":"2012","journal-title":"Virus Res."},{"issue":"2","key":"10.1016\/j.peptides.2022.170844_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007584","article-title":"Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants","volume":"15","author":"Trobaugh","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.peptides.2022.170844_bib23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.omtm.2020.04.009","article-title":"Nanoplasmid vectors co-expressing innate immune agonists enhance DNA vaccines for venezuelan equine encephalitis virus and ebola virus","volume":"17","author":"Suschak","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7010029","article-title":"Plasmid DNA-based alphavirus vaccines","volume":"7","author":"Lundstrom","year":"2019","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.peptides.2022.170844_bib25","article-title":"Vaccine advances against venezuelan, eastern, and western equine encephalitis viruses","volume":"8","author":"Stromberg","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.peptides.2022.170844_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2016.06.025","article-title":"Two novel epistatic mutations (E1:K211E and E2:V264A) in structural proteins of Chikungunya virus enhance fitness in Aedes aegypti","volume":"497","author":"Agarwal","year":"2016","journal-title":"Virology"},{"issue":"36","key":"10.1016\/j.peptides.2022.170844_bib27","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1016\/j.vaccine.2009.02.090","article-title":"Immune interference after sequential alphavirus vaccine vaccinations","volume":"27","author":"Pittman","year":"2009","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.peptides.2022.170844_bib28","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1016\/j.vaccine.2012.09.049","article-title":"Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis","volume":"30","author":"Reisler","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.peptides.2022.170844_bib29","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1021\/acsbiomaterials.2c00015","article-title":"Development of an intranasal gel for the delivery of a broadly acting subunit influenza vaccine","volume":"8","author":"Varma","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.peptides.2022.170844_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2022.05.017","article-title":"STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant","author":"Gallovic","year":"2022","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.peptides.2022.170844_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jmb.2009.11.070","article-title":"PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype","volume":"396","author":"Danecek","year":"2010","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.peptides.2022.170844_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1504\/IJBRA.2010.032117","article-title":"Flavitrack analysis of the structure and function of West Nile non-structural proteins","volume":"6","author":"Danecek","year":"2010","journal-title":"Int J. Bioinform. Res. Appl."},{"issue":"19","key":"10.1016\/j.peptides.2022.170844_bib33","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/bioinformatics\/btm383","article-title":"Flavitrack: an annotated database of flavivirus sequences","volume":"23","author":"Misra","year":"2007","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.peptides.2022.170844_bib34","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3201\/eid2710.211538","article-title":"Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19","volume":"27","author":"Focosi","year":"2021","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib35","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41598-022-04950-4","article-title":"Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis","volume":"12","author":"Negi","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.peptides.2022.170844_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4269\/ajtmh.14-0055","article-title":"Current strategic thinking for the development of a trivalent alphavirus vaccine for human use","volume":"91","author":"Wolfe","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.peptides.2022.170844_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00052-4","article-title":"Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial","author":"Coates","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.peptides.2022.170844_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2012.04.002","article-title":"Alphaviruses: population genetics and determinants of emergence","volume":"94","author":"Weaver","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.peptides.2022.170844_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2020.11.010","article-title":"Designing multivalent immunogens for alphavirus vaccine optimization","volume":"561","author":"Read","year":"2021","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.peptides.2022.170844_bib40","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1016\/j.cell.2021.07.033","article-title":"Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress","volume":"184","author":"Williamson","year":"2021","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.peptides.2022.170844_bib41","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.cell.2021.07.006","article-title":"Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope","volume":"184","author":"Kim","year":"2021","journal-title":"Cell"},{"issue":"44","key":"10.1016\/j.peptides.2022.170844_bib42","doi-asserted-by":"crossref","first-page":"27637","DOI":"10.1073\/pnas.2008051117","article-title":"Structural basis of Chikungunya virus inhibition by monoclonal antibodies","volume":"117","author":"Zhou","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.peptides.2022.170844_bib43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chom.2020.07.008","article-title":"Human mAbs broadly protect against arthritogenic alphaviruses by recognizing conserved elements of the mxra8 receptor-binding site","volume":"28","author":"Powell","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41564-018-0286-4","article-title":"Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein","volume":"4","author":"Kim","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"5","key":"10.1016\/j.peptides.2022.170844_bib45","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2015.10.050","article-title":"Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress","volume":"163","author":"Fox","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2022.170844_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104905","article-title":"Producing physicochemical property consensus alphavirus protein antigens for broad spectrum vaccine design","volume":"182","author":"Baker","year":"2020","journal-title":"Antivir. Res"},{"issue":"10","key":"10.1016\/j.peptides.2022.170844_bib47","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3201\/eid2510.181610","article-title":"Localized outbreaks of epidemic polyarthritis among military personnel caused by different sublineages of ross river virus, Northeastern Australia, 2016-2017","volume":"25","author":"Liu","year":"2019","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.peptides.2022.170844_bib48","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/prot.22281","article-title":"Mechanical stability and differentially conserved physical-chemical properties of titin Ig-domains","volume":"75","author":"Garcia","year":"2009","journal-title":"Proteins"},{"issue":"4","key":"10.1016\/j.peptides.2022.170844_bib49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molimm.2008.07.034","article-title":"Characteristic motifs for families of allergenic proteins","volume":"46","author":"Ivanciuc","year":"2009","journal-title":"Mol. Immunol."},{"issue":"31","key":"10.1016\/j.peptides.2022.170844_bib50","doi-asserted-by":"crossref","first-page":"21808","DOI":"10.1074\/jbc.M708582200","article-title":"Identification and analysis of conserved sequence motifs in cytochrome P450 family 2. Functional and structural role of a motif 187RFDYKD192 in CYP2B enzymes","volume":"283","author":"Oezguen","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.peptides.2022.170844_bib51","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00894-001-0058-5","article-title":"New quantitative descriptors of amino acids based on multidimensional scaling of a large number of physical-chemical properties","volume":"7","author":"Venkatarajan","year":"2001","journal-title":"J. Mol. Model"},{"issue":"42","key":"10.1016\/j.peptides.2022.170844_bib52","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1016\/j.vaccine.2012.07.042","article-title":"Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes","volume":"30","author":"Bowen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.peptides.2022.170844_bib53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2015.05.016","article-title":"Sequence specificity for uridylylation of the viral peptide linked to the genome (VPg) of enteroviruses","volume":"484","author":"Schein","year":"2015","journal-title":"Virology"},{"issue":"40","key":"10.1016\/j.peptides.2022.170844_bib54","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.peptides.2022.170844_bib55","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and characterization of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.peptides.2022.170844_bib56","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"Giles","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virol.2010.03.038","article-title":"Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III","volume":"403","author":"Zhang","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2022.170844_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/11779322211020316","article-title":"DGraph clusters flaviviruses and beta-coronaviruses according to their hosts, disease type, and human cell receptors","volume":"15","author":"Braun","year":"2021","journal-title":"Bioinform. Biol. Insights"},{"issue":"7324","key":"10.1016\/j.peptides.2022.170844_bib59","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.peptides.2022.170844_bib60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W","article-title":"Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules","volume":"19","author":"Fraczkiewicz","year":"1998","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(87)90135-7","article-title":"Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra","volume":"167","author":"Manavalan","year":"1987","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.peptides.2022.170844_bib62","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/abio.2000.4880","article-title":"Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set","volume":"287","author":"Sreerama","year":"2000","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prot.20676","article-title":"The protein circular dichroism data bank (PCDDB): a bioinformatics and spectroscopic resource","volume":"62","author":"Wallace","year":"2006","journal-title":"Proteins"},{"issue":"2","key":"10.1016\/j.peptides.2022.170844_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virol.2012.11.013","article-title":"IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice","volume":"437","author":"Rossi","year":"2013","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.peptides.2022.170844_bib65","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1128\/JVI.06449-11","article-title":"Attenuation of Chikungunya virus vaccine strain 181\/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein","volume":"86","author":"Gorchakov","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2022.170844_bib66","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4269\/ajtmh.1964.13.723","article-title":"The Venezuelan equine encephalomyelitis complex of group a arthropod-borne viruses, including mucambo and pixuna from the Amazon region of Brazil","volume":"13","author":"Shope","year":"1964","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.peptides.2022.170844_bib67","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1128\/JVI.02364-15","article-title":"Structural studies of chikungunya virus-like particles complexed with human antibodies: neutralization and cell-to-cell transmission","volume":"90","author":"Porta","year":"2016","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.peptides.2022.170844_bib68","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2015.10.050","article-title":"Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress","volume":"163","author":"Fox","year":"2015","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.peptides.2022.170844_bib69","doi-asserted-by":"crossref","first-page":"14364","DOI":"10.1128\/JVI.01943-14","article-title":"Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy","volume":"88","author":"Fong","year":"2014","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.peptides.2022.170844_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003684","article-title":"A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice","volume":"9","author":"Weber","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2011.03.030","article-title":"Differential accumulation of genetic and phenotypic changes in Venezuelan equine encephalitis virus and Japanese encephalitis virus following passage in vitro and in vivo","volume":"415","author":"McCurdy","year":"2011","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.peptides.2022.170844_bib72","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1128\/JVI.01286-14","article-title":"Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies","volume":"88","author":"Porta","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.peptides.2022.170844_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01495-20","article-title":"High-resolution mapping of human norovirus antigens via genomic phage display library selections and deep sequencing","volume":"95","author":"Huang","year":"2020","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.peptides.2022.170844_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/v11080748","article-title":"ZIKV envelope domain-specific antibodies: production, purification and characterization","volume":"11","author":"Akhras","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.peptides.2022.170844_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170583","article-title":"Synthetic proteins for COVID-19 diagnostics","volume":"143","author":"Schein","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2022.170844_bib76","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molimm.2020.03.017","article-title":"Epitopes with similar physicochemical properties contribute to cross reactivity between peanut and tree nuts","volume":"122","author":"Nesbit","year":"2020","journal-title":"Mol. Immunol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978122001103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978122001103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:32:21Z","timestamp":1759311141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978122001103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":76,"alternative-id":["S0196978122001103"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2022.170844","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCP consensus protein\/peptide alphavirus antigens stimulate broad spectrum neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2022.170844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170844"}}